Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2018 08:00 ET | Source: Noxopharm, Ltd.

NOX to Present Clinical Data at COSA Annual Meeting

Clinical Oncology Society of AustraliaProvides updates on CEP-1 and DARRT-1 clinical studiesConfirms tolerability of Veyonda®Evidence of durable halt of tumour progression in both studies SYDNEY,...
October 04, 2018 08:00 ET | Source: Noxopharm, Ltd.

Noxopharm Releases Report on Key Progress of Subsidiary Nyrada

Important progress reported across the Nyrada therapeutic pipelinePotential first-in-class drugs in development for multiple large underserved indications, including cardiovascular disease, stroke...